Page last updated: 2024-09-03

ym 022 and Disease Models, Animal

ym 022 has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Boyce, M; Burkitt, MD; Dodd, S; Duckworth, CA; Exarchou, K; Fang, Y; Hall, N; Howes, N; Lloyd, KA; Moore, AR; Oxvig, C; Papoutsopoulou, S; Parsons, BN; Pritchard, DM; Rainbow, L; Varro, A1
De Felice, M; Guo, W; King, T; Ossipov, MH; Porreca, F; Wang, R1
Fox, JG; Lee, CW; Muthupalani, S; Rickman, B; Rogers, AB; Takaishi, S; Wang, TC; Yang, P1
Chen, P; Lingen, M; Sonis, ST; Toback, FG; Walsh-Reitz, MM1
Attoub, S; Bado, A; Barbier, M; Cherbut, C; Galmiche, JP; Joubert, M; Laboisse, C1

Trials

1 trial(s) available for ym 022 and Disease Models, Animal

ArticleYear
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
    Cellular and molecular gastroenterology and hepatology, 2020, Volume: 10, Issue:1

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Cell Line, Tumor; Disease Models, Animal; Gastric Mucosa; Gastrins; Gene Knockdown Techniques; Humans; Mice; Mice, Transgenic; Neuroendocrine Tumors; Organoids; Phenylurea Compounds; Pregnancy-Associated Plasma Protein-A; Primary Cell Culture; Receptor, Cholecystokinin B; Stomach Neoplasms; Treatment Outcome

2020

Other Studies

4 other study(ies) available for ym 022 and Disease Models, Animal

ArticleYear
Descending facilitation maintains long-term spontaneous neuropathic pain.
    The journal of pain, 2013, Volume: 14, Issue:8

    Topics: Afferent Pathways; Anesthetics, Local; Animals; Benzodiazepines; Conditioning, Operant; Disease Models, Animal; Hormone Antagonists; Hyperalgesia; Lidocaine; Male; Medulla Oblongata; Neuralgia; Oncogene Proteins v-fos; Ondansetron; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Spinal Nerves; Time Factors

2013
Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
    Cancer research, 2009, Oct-15, Volume: 69, Issue:20

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Benzodiazepines; Blotting, Western; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Hormone Antagonists; Hydrogen-Ion Concentration; Interferon-gamma; Male; Membrane Proteins; Mice; Precancerous Conditions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Sulindac; Tumor Necrosis Factor-alpha

2009
Role of AMP-18 in oral mucositis.
    Oral oncology, 2011, Volume: 47, Issue:9

    Topics: Adherens Junctions; Animals; Benzodiazepines; Disease Models, Animal; Female; Fluorescent Antibody Technique; Humans; Keratinocytes; Mass Spectrometry; Mice; Mucous Membrane; Peptide Hormones; Receptor, Cholecystokinin B; Recombinant Proteins; Stomatitis; Tight Junctions

2011
Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.
    Life sciences, 2001, Jun-22, Volume: 69, Issue:5

    Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Benzodiazepines; Colitis; Disease Models, Animal; Ethanolamines; Hormone Antagonists; Inflammatory Bowel Diseases; Leptin; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3; Receptors, Cholecystokinin; Severity of Illness Index

2001